Clik here to view.
蔓越莓汁可能有助于预防心脏病和糖尿病的危险因素
马萨诸塞州LAKEVILLE-MIDDLEBORO (美国商业资讯)–一项最新研究1显示，饮用低热量蔓越莓汁鸡尾酒可能有助于降低一些慢性病的风险，这些慢性病是世界各地位居前列的死因，包括心脏病、糖尿病和卒中。鉴于世界卫生组织估计这三种疾病的全球年致死人数达1560万例，该发现是一条受人欢迎的新闻。2...
View ArticleClik here to view.
Overcoming Challenges in Sequence Analysis of FFPE Tissue Due to...
BOLOGNA, Italy Silicon Biosystems, a Bologna (Italy) and San Diego (CA, USA) based biotech company that is part of the pharmaceutical Menarini Group, presented recent findings obtained with its...
View ArticleClik here to view.
Israeli Implant Company A.B. Dental Devices Ltd. to Enter a Partnership with...
ASHDOD, Israel Implant company A.B. Dental from Israel signed a triple partnership agreement to distribute dental implants and provide training courses in China, Hong Kong, and Macau. The agreement...
View ArticleClik here to view.
GlySure Secures CE Mark and Launches World’s First Continuous Intravascular...
ABINGDON, England GlySure Limited today announced that it has secured the CE Mark for the world’s first and only Continuous Intravascular Glucose Monitoring System (CIGMS). The initial use of the...
View ArticleClik here to view.
Dr. Reddy’s Unveils New Corporate Brand Identity
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) today announced the launch of its new visual identity and brand, that will guide its actions across the globe: Good Health Can’t Wait. The new...
View ArticleClik here to view.
NuGEN Scientists Screen 400+ Genes for Fusion Events in Single Assay; Detect...
SAN CARLOS, Calif. Scientists at NuGEN Technologies, Inc. have simultaneously surveyed RNA of more than 400 targeted genes in a single assay, using next generation sequencing (NGS) to detect fusions...
View ArticleClik here to view.
Provectus Biopharmaceuticals Signs Letter of Intent with Boehringer Ingelheim...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”),...
View ArticleClik here to view.
Quintiles and Quest Diagnostics Launch Q2 Solutions
RESEARCH TRIANGLE PARK, N.C. & MADISON, N.J. Quintiles and Quest Diagnostics today announced the launch of Q2 Solutions, their new combined clinical trials laboratory services organization. Q2...
View ArticleClik here to view.
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Harvoni®,...
FOSTER CITY, Calif. Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg),...
View ArticleClik here to view.
Technavio Says the Increased Acceptance of Connected Services Will Expedite...
LONDON Technavio has published a new report on the smartwatch market in Japan, which is expected to grow at a CAGR exceeding 96% from 2015-2019. About the Report The new report by Technavio...
View ArticleClik here to view.
LENSAR Expands Presence in India; Sharp Sight Centres Choose the LENSAR Laser...
ORLANDO, Fla. & DELHI, India LENSAR, Inc., a global leader in next generation femtosecond laser technology for refractive cataract surgery, today announced the Sharp Sight Centres now offer the...
View ArticleClik here to view.
Provectus Biopharmaceuticals’ Phase 1 PV-10 Data on Liver Cancer Presented at...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biopharmaceutical company (“Provectus” or the “Company”),...
View ArticleClik here to view.
India’s Refractive Surgery Society Awards Special Gold Medal to LENSAR CEO...
ORLANDO, Fla. & CHENNAI, India The Intraocular Implant and Refractive Society of India (IIRSI) awarded a Special Gold Medal to Nicholas T. Curtis, CEO of LENSAR, Inc., a global leader in next...
View ArticleClik here to view.
クインタイルズとクエスト・ダイアグノスティクスがQ2ソリューションズを創立
米ノースカロライナ州リサーチ・トライアングル・パーク & ニュージャージー州マディソン （ビジネスワイヤ） —...
View ArticleClik here to view.
昆泰与Quest Diagnostics推出Q2 Solutions
北卡罗莱纳州研究三角园区和纽约州麦迪逊 (美国商业资讯)–昆泰和Quest Diagnostics今天宣布推出其联合临床试验实验室服务公司Q2 Solutions。Q2 Solutions汇总了两家母公司的临床试验实验室业务，可为生物制药业客户提供生物制药业快速演进所需的多元化能力和端到端服务。今天推出的Q2 Solutions是之前宣布的全球性临床试验实验室服务合资企业交易完成的结果。...
View ArticleClik here to view.
Spok and Xovic Partner to Improve Critical Communications for Thailand Hospitals
PERTH, Australia Spok, Inc. today announced that it has partnered with Thailand-based medical distributor Xovic to enable healthcare organisations to improve efficiency and safety with better staff...
View ArticleClik here to view.
Global Disposable Plastic Blood Bags Market to Hit US$413 million by 2020:...
NEW YORK Persistence Market Research has published a new market report titled, “Global Market Study on Disposable Plastic Blood Bags: Single Blood Bags to Witness Highest Growth by 2020” that states...
View ArticleClik here to view.
AstraZeneca and Ironwood Report Positive Top-Line Data from Phase III IBS-C...
SHANGHAI & CAMBRIDGE, Mass. AstraZeneca Pharmaceuticals Co., Ltd. and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that top-line data demonstrate linaclotide met all primary and...
View ArticleClik here to view.
新規抗精神病薬「REXULTI®（レキサルティ）」 成人の統合失調症と大うつ病補助療法の2つの適応で米国FDAが承認
東京 （ビジネスワイヤ） — 大塚製薬株式会社（本社：東京都、代表取締役社長：樋口達夫、以下「大塚製薬」）とH.ルンドベックA/S（本社：デンマーク、コペンハーゲン、社長兼CEO：コア・シュルツ、以下「ルンドベック社」）は...
View ArticleClik here to view.
U.S. FDA Approves Otsuka and Lundbeck’s REXULTI® (Brexpiprazole) as...
TOKYO & VALBY, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced today that the U.S. Food and Drug Administration (FDA) approved REXULTI® (brexpiprazole)...
View Article